BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KI Science Park - ECPv6.15.0.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KI Science Park
X-ORIGINAL-URL:https://www.kisciencepark.kisciencepark.hemsida.eu
X-WR-CALDESC:Events for KI Science Park
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240503T140000
DTEND;TZID=Europe/Stockholm:20240503T151500
DTSTAMP:20260422T073652
CREATED:20240420T070231Z
LAST-MODIFIED:20240420T070231Z
UID:10000079-1714744800-1714749300@www.kisciencepark.kisciencepark.hemsida.eu
SUMMARY:Using Public-Private Partnerships for Discovery\, Development and Delivery of Vaccines
DESCRIPTION:The International Vaccine Institute (IVI) invites you to the scientific symposium: ‘Using Public-Private Partnerships for the Discovery\, Development\, and Delivery of Vaccines’. \n\n\n\n\nRecent pandemic outbreaks have underscored the urgent need for enhanced global cooperation to tackle future threats and develop safer vaccines. With over 27 years of experience in building cooperation between public and private sectors\, IVI has been instrumental in facilitating vaccine development and improving health access for vulnerable populations worldwide. In line with its commitment to strengthening international partnerships\, IVI is opening its permanent office in Stockholm on 3rd of May 2024. To commemorate this milestone\, IVI organizes a symposium aimed at fostering dialogue and collaboration in vaccine research and public health initiatives. \nRegister here! \nThe symposium will offer an opportunity to learn from some prominent scholars within vaccine development and public health about several examples of cooperation that resulted in the successful deployment of vaccines and saving lives worldwide. \nSPEAKERS \nJan Holmgren\, senior professor of medical microbiology\, renowned for his groundbreaking research on cholera\, will share his insights of oral cholera vaccine development – from discovery to delivery in low- and middle-income countries. \n\n\n\n\n\n\nDr. Manki Song\, Deputy Director General at IVI\, will address the topic of vaccine self- sufficiency in Korea and the collaborative role played by IVI. \nDr. Anh Wartel\, Director of the IVI Europe Regional Office\, will offer her prospective on IVI’s mission and goals in Europe and discuss how IVI works using public-private partnerships. \nThe symposium will conclude with a panel discussion\, focusing on current challenges of vaccine development for chikungunya\, a viral disease that is causing large-scale outbreaks around the world. \n\nAbout the event and contact \nThe event welcomes scholars\, experts and policymakers to join and explore how various financial support models and partnerships can help facilitate deployment of vaccines for world’s most vulnerable populations. Professor Jan Holmgren from Gothenburg University\, renowned for his groundbreaking research on cholera\, is the keynote speaker at the event. \nFor accreditation to the event as a journalist\, please contact Elena Krivovyaz Communications Manager\, Europe Regional Office | E-mail: elena.krivovyaz@ivi.int \n\nMore about IVI \nIVI is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover\, develop and deliver safe\, effective and affordable vaccines for global health. IVI is headquartered in Seoul\, Republic of Korea\, with a Europe Regional Office in Sweden\, a Country office in Austria\, the Hong Kong Jockey Club Global Health Institute\, and two offices to be opened in Rwanda and Kenya. IVI also has collaborating centers in Ghana\, Ethiopia and Madagascar. IVI has 39 countries and the World Health Organization (WHO) on its treaty\, including the Republic of Korea\, Sweden\, India\, Thailand and Finland as state funders. \nIVI created the world’s first low-cost oral cholera vaccine\, pre-qualified by the WHO and developed a new-generation typhoid conjugate vaccine that is currently under assessment for WHO Prequalification. To date\, over 56 million doses of these low-cost OCVs have been deployed worldwide. IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionally affect low- and middle- income countries\, such as cholera\, typhoid\, chikungunya\, shigella\, salmonella\, schistosomiasis\, hepatitis E\, Human Papilloma Virus (HPV) and COVID-19\, as well as antimicrobial resistance. \nFor more information\, visit our website: https://www.ivi.int/
URL:https://www.kisciencepark.kisciencepark.hemsida.eu/event/using-public-private-partnerships-for-discovery-development-and-delivery-of-vaccines/
LOCATION:Andreas Vesalius lecture hall\,\, Berzelius väg 35\, Campus Solna\, Solna\, 17165
ATTACH;FMTTYPE=image/jpeg:https://www.kisciencepark.kisciencepark.hemsida.eu/wp-content/uploads/2024/04/symposiumivipromo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240517T120000
DTEND;TZID=Europe/Stockholm:20240517T125500
DTSTAMP:20260422T073652
CREATED:20240401T195910Z
LAST-MODIFIED:20240515T084407Z
UID:10000073-1715947200-1715950500@www.kisciencepark.kisciencepark.hemsida.eu
SUMMARY:KI Science Park's CEO and Business Leader Lunch at Nobels Väg 16: meet Basic-Genomics\, Countagen and Ebba Biotech.
DESCRIPTION:KI Science Park member network  | By invitation only \nWelcome to KI Science Park CEO and Business Leader Lunch at Nobels Väg 16 \nJoin us for this networking opportunity  that combines lunch with influential minds!   \nThis month three members jointly inviting you to Nobels Väg 16:  Gert-Jan Hendriks CEO at Basic Genomics\, Felix Neumann CEO at Coutagen and Smilla Huzell COO at Ebba Biotech. They will present them self’s and their business. \nAs always\, we will have time for questions and an open discussion round the table. A light lunch will be served. \nRegister here! \n  \nWe look forward to welcoming you! \nGert-Jan Hendriks CEO at Basic Genomics\,\nFelix Neumann CEO at Coutagen and\nSmilla Huzell COO at Ebba Biotech\nSara Gunnerås\, COO at KI Science Park \n__________________________________________________ \nABOUT  \nThe CEO and Business Leader Lunch is a monthly networking event exclusively for CEOs and business leaders of our community. It fosters connections\, strengthens networks among KI Science Park members\, and welcomes new companies on Campus Solna. It provides a platform for insightful discussions\, idea exchange\, and potential collaborations. \n 
URL:https://www.kisciencepark.kisciencepark.hemsida.eu/event/ki-science-parks-ceo-and-business-leader-lunch-may24/
ATTACH;FMTTYPE=image/jpeg:https://www.kisciencepark.kisciencepark.hemsida.eu/wp-content/uploads/2024/04/2024-ceo-lunch-flyers-orginal.jpg
ORGANIZER;CN="KI Science Park":MAILTO:event@kisciencepark.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240520T114500
DTEND;TZID=Europe/Stockholm:20240520T130000
DTSTAMP:20260422T073652
CREATED:20240506T153909Z
LAST-MODIFIED:20240506T153914Z
UID:10000080-1716205500-1716210000@www.kisciencepark.kisciencepark.hemsida.eu
SUMMARY:KI Science Park Lunch Talks hosted by Bayer: Hur säkerställer vi att fler får tillgång till kliniska prövningar?
DESCRIPTION:Välkommen till en serie av lunchsamtal kring de stora frågorna inom life science och hälso- och sjukvård! \nHur säkerställer vi att fler får tillgång till kliniska prövningar?  \n– ett samarbete mellan Bayer\, KI Science Park och Waters Corporation. \nAntalet kliniska prövningar minskar\, sett över tid\, i Sverige och det innebär att färre patienter får tillgång till innovativa behandlingar som i vissa fall kan vara livsavgörande. Regeringen har genom Peter Asplunds utredning presenterat förslag till förändringar. Hur ska fler patienter framgent få tillgång till kliniska prövningar och vad behöver göras? Vilken roll ska staten ha och vad kan regionerna göra för att det ska bli skillnad? \nDeltagare i samtalet är Peter Asplund\, regeringens tidigare utredare i frågan\, Gunilla Andrew-Nielsen\, enhetschef Kliniska prövningar m.m. Läkemedelsverket\, Catharina Östberg\, Bayer\, chef kliniska prövningar norra Europa\, Amelie Tarschys Ingre regionråd (L) Region Stockholm\, Kristina Kannisto forskningsstrateg Region Stockholm\, Karl Bergman\, VD Elypta. \nModerator: Edvard Agrell\, Bayer.            \nRegister here! \nAnmäl dig på en gång för att säkra din plats\, men senast den 17 maj\, glöm inte att bekräfta som sista steg i din anmälan! \nVi bjuder på lättare lunch. \nVarmt välkommen! \n 
URL:https://www.kisciencepark.kisciencepark.hemsida.eu/event/ki-science-park-lunch-talks-kliniska-provningar/
LOCATION:Bayer office at Campus Solna\, Nobels väg 8\, Solna\, 171 65
ATTACH;FMTTYPE=image/jpeg:https://www.kisciencepark.kisciencepark.hemsida.eu/wp-content/uploads/2024/05/240520-lunch-talks-klin-provn.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240521T110000
DTEND;TZID=Europe/Stockholm:20240521T130000
DTSTAMP:20260422T073652
CREATED:20240401T201729Z
LAST-MODIFIED:20240520T092050Z
UID:10000074-1716289200-1716296400@www.kisciencepark.kisciencepark.hemsida.eu
SUMMARY:KI Science Park Lab Network
DESCRIPTION:KI Science Park Lab Network no.2\nAt this second meeting we will focus on forming interest groups to make the content of future lab meetings more specialised. The meeting is also a great opportunity for networking with other lab enthusiasts over lunch. \nRegister here! \nPlease share this invitation with the persons in your company that could be interested in joining this meeting. Ideally someone actively working in the lab or having overview about lab operations and needs. \nNote that we meet at a new location this time to get to know Campus Solna even better. So\, welcome to Nobels Väg 16! \nAGENDA\n11.00-11.15 – Meet and greet.\n11.15-11.30 – Welcome and about today’s topic/workshop.\n11.30-12.15 – Workshop & lunch\n12.15-12.30 – Summary + actions & coffee \nNote that we meet at a new location this time to get to know Campus Solna even better. So\, welcome to Nobels Väg 16! \nPlease share this invitation with the persons in your company that could be interested in joining. Ideally someone actively working in the lab or having overview about lab operations and needs. \nWe look forward to welcoming you!\nArmando Cázares-Körner\, PhD\, Lab Manager at A Working Lab\nSara Gunnerås\, PhD\, COO and Community Manager at KI Science Park \nQuestions?\nArmando.CazaresKorner@akademiskahus.se\nSara.Gunneras@kisciencepark.se \n_______________________ \nAbout the Lab Network\nThe Lab Network provides a network for laboratory managers and researchers att KI Science Park member companies to share knowledge and resources. It will encourage a collaborative environment to look at how we can work together\, and explore synergies to drive sustainability. The KI Science Park LAB Network is i coordinated by KI Science Park AB and A Working Lab.
URL:https://www.kisciencepark.kisciencepark.hemsida.eu/event/ki-science-park-lab-network-may24/
ATTACH;FMTTYPE=image/jpeg:https://www.kisciencepark.kisciencepark.hemsida.eu/wp-content/uploads/2024/03/2024-the-lab-network-placeholder-2.jpg
ORGANIZER;CN="KI Science Park":MAILTO:event@kisciencepark.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240523T074000
DTEND;TZID=Europe/Stockholm:20240523T090000
DTSTAMP:20260422T073652
CREATED:20240418T064739Z
LAST-MODIFIED:20250124T161957Z
UID:10000078-1716450000-1716454800@www.kisciencepark.kisciencepark.hemsida.eu
SUMMARY:KI Science Park Business Breakfast: Fredrik Olsson\, CEO at Genovis
DESCRIPTION:Meet Fredrik Olsson\, CEO at Genovis – Winner of SwedenBIO award 2024.  \n\nRegister here! \n\nFredrik will share the story about Genovis and how their SmartEnzymes conquered the world. \nGenovis provides enzymes and technologies for analytical characterization and conjugation of biopharmaceuticals. The company has launched several products and partnered with a number of international companies leading to rapid growth. \nAs many stories it started with a brilliant idea and was followed by a long winding journey. Eventually is became a success and 2024 Genovis won the SwedenBIO award! \nAbout Fredrik Olsson  \nFredik is an experienced Chief Executive Officer from the biotechnology industry on a global level. He has a long experience in sales and business development and a passion for creating value for customers and other stakeholders. \nFredrik graduated from The Faculty of Engineering at Lund University and skilled in Research and Development (R&D)\, Protein Chemistry\, High-Performance Liquid Chromatography (HPLC)\, and Molecular Biology. He is also co-author of several scientific publications and patents. \n\nPROGRAM\n7:40 – 8:00 Breakfast is served.\n8:00 – 8:05 Welcome by KI Science Park\n8:05 – 8:35 Presentation by invited guest\n8:35 – 9:00 Q&A \nWarm welcome!\n \n\nAbout Business Breakfast\nBusiness Breakfast is KI Science Park’s monthly networking event where we invite business leaders to share their expertise and experience with the community and spotlighting current topics in Life Science.
URL:https://www.kisciencepark.kisciencepark.hemsida.eu/event/ki-science-park-business-breakfast-genovis/
LOCATION:Innomedicum\, A Working Lab Cafe  |\, Nanna Svartz Väg 4\, Solna\, 171 65
ATTACH;FMTTYPE=image/jpeg:https://www.kisciencepark.kisciencepark.hemsida.eu/wp-content/uploads/2024/04/240523-bb-v2-flyers-olsson-genovis.jpg
ORGANIZER;CN="KI Science Park":MAILTO:event@kisciencepark.se
END:VEVENT
END:VCALENDAR